Company: RPTX
Filing Date: 2025-12-03
Form Type: PREM14A
Source: 0001193125-25-306948
Chunk: 151

Company: Repare Therapeutics Inc.
Filing Date: 2025-12-03
Form: PREM14A
Chunk 151
---
isable within 60 days of the Record Date. OrbiMed Capital GP VII LLC (“OrbiMed GP”) is the general partner of OPI VII, 
 pursuant to the terms of the limited partnership agreement of OPI VII, and OrbiMed Advisors LLC (“OrbiMed Advisors”) is the managing member of OrbiMed GP, pursuant                                                                     |

92

| to the terms of the limited liability company agreement of OrbiMed GP. As a result, OrbiMed Advisors and OrbiMed GP share power to direct the vote and disposition of the Common Shares held by OPI                                                    
 VII and may be deemed directly or indirectly, including by reason of their mutual affiliation, to be the beneficial owners of the Common Shares held by OPI VII. OrbiMed Advisors exercises this investment and voting power through a management      
 committee comprised of Carl L. Gordon, Sven H. Borho, and W. Carter Neild, each of whom disclaims beneficial ownership of the Common Shares held by OPI VII. David Bonita, M.D., a member of our board of directors, is a member of OrbiMed Advisors.  
 OrbiMed Capital LLC (“OrbiMed Capital”) is the investment advisor of each of BIOG and OPM. As a result, OrbiMed Capital has the power to direct the vote and disposition of the Common Shares held by BIOG and OPM and may be deemed directly          
 or indirectly, including by reason of mutual affiliation, to be the beneficial owner of the Common Shares held by BIOG and OPM. OrbiMed Capital exercises this investment and voting power through a management committee comprised of Carl L. Gordon, 
 Sven H. Borho, and W. Carter Neild, each of whom disclaims beneficial ownership of the Common Shares held by BIOG and OPM. Dr. Bonita is a member of OrbiMed Capital. The address of each of the above persons and entities is 601 Lexington Avenue,   
 54th Floor, New York, NY 10022.                                                                                                                                                                                                                        |

| (9) | Consists of (a) 7,500 Common Shares held by Mr. Civik and (b) 145,400 Common Shares issuable upon the                                 
 exercise of options granted to Mr. Civik that are currently exercisable or will become exercisable within 60 days of the Record Date. |

| (10) | Consists of 195,333 Common Shares issuable upon the exercise of options granted to Dr. Kulk